Urokinase receptor is up-regulated in endothelial cells and macrophages associated with fibrinoid deposits in the human placenta

Placenta

Volumn 24, Issue 6, 2003, Pages 677-685

  Pierleoni, C ^a,d   Castellucci, M ^a   Kaufmann, P ^b   Lund, L R ^c   Nielsen, B Schnack ^c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c FINSEN LABORATORY   (Denmark)

^d LEO PHARMA A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; CD31 ANTIGEN; ENZYME PRECURSOR; INTEGRIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; UROKINASE RECEPTOR; VON WILLEBRAND FACTOR;

ARTICLE; CELL POPULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MOLECULAR MECHANICS; PLACENTA; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLAST; UPREGULATION;

EID: 0141838058     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(03)00082-1     Document Type: Article

References (66)

1. Alexander CM & Werb Z (1989) Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol, 1, 974-982.
2. Altieri DC, Bader R, Mannucci PM & Edgington TS (1988) Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol, 107, 1893-1900.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G & Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275, 964-967.
4. Bardos H, Molnar P, Csecsei G & Adany R (1996) Fibrin deposition in primary and metastatic human brain tumours. Blood Coagul Fibrinolysis, 7, 536-548.
5. Behrendt N, Jensen ON, Engelholm LH, Mortz E, Mann M & Danø K (2000) A urokinase receptor-associated protein with specific collagen binding properties. J Biol Chem, 275, 1993-2002.
6. Behrendt N & Stephens R (1998) The urokinase receptor. Fibrinolysis and Proteolysis, 12, 191-204.
7. Benirschke K & Kaufmann P (2000) Pathology of the Human Placenta, 4th edn. New York: Springer Publishers p. 24 and p. 214.
8. Beschorner R, Schluesener HJ, Nguyen TD, Magdolen V, Luther T, Pedal I, Mattern R, Meyermann R & Schwab JM (2000) Lesion-associated accumulation of uPAR/CD87-expressing infiltrating granulocytes, activated microglial cells/macrophages and upregulation by endothelial cells following TBI and FCI in humans. Neuropathol Appl Neurobiol, 26, 522-527.
9. Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Rømer J, Danø K, Carmeliet P, Collen D & Degen J (1996a) Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci, 93, 5899-5904.
10. Bugge TH, Flick MJ, Daugherty CC & Degen JL (1995) Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev, 9, 794-807.
11. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ & Degen JL (1996b) Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell, 87, 709-719.
12. Byrne S, Cheent A, Dimond J, Fisher G & Ockleford CD (2001) Immunocytochemical localization of a caveolin-1 isoform in human term extra-embryonic membranes using confocal laser scanning microscopy: implications for the complexity of the materno-fetal junction. Placenta, 22, 499-510.
13. Carmeliet P & Collen D (1998) Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res, 91, 255-285.
14. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D & Mulligan RC (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature, 368, 419-424.
15. Castellucci M, Kosanke G, Verdenelli F, Huppertz B & Kaufmann P (2000) Villous sprouting: fundamental mechanisms of human placental development. Hum Reprod Update, 6, 485-494.
16. Castellucci M, Scheper M, Scheffen I, Celona A & Kaufmann P (1990) The development of the human placental villous tree. Anal Embryol (Berl), 181, 117-128.
17. Chen ZL & Strickland S (1997) Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell, 91, 917-925.
18. Danø K, Andreasen PA, Grøndahl-Hansen J, Kristensen P, Nielsen LS & Skriver L (1985) Plasminogen activators, tissue degradation and cancer. Adv Cancer Res, 44, 139-266.
19. Danø K, Rømer J, Nielsen BS, Bjørn SF, Pyke C, Rygaard J & Lund LR (1999) Cancer invasion and tissue remodeling-cooperation of protease systems and cell types. APMIS, 107, 120-127.
20. Dubuisson L, Monvoisin A, Nielsen BS, Le Bail B, Bioulac-Sage P & Rosenbaum J (2000) Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in hepatocellular carcinomas. J Pathol, 190, 190-195.
21. Ellis V & Danø K (1993) Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation. J Biol Chem, 268, 4806-4813.
22. Ellis V, Scully MF & Kakkar VV (1989) Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem, 264, 2185-2188.
23. Engelholm LH, Nielsen BS, Netzel-Arnett S, Solberg H, Chen X-D, Lopez JM, Lopez-Otin C, Young MF, Birkedal-Hansen H, Danø K, Lund LR, Behrendt N & Bugge TH (2001) The urokinase plasminogen activator receptor-associated protein/Endo180 is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloproteinase-13 during osteogenesis. Lab Invest, 81, 1403-1414.
24. Falini B, Flenghi L, Pileri S, Gambacorta M, Bigerna B, Durkop H, Eitelbach F, Thiele J, Pacini R, Cavaliere A, Martelli M, Cardarelli N, Sabattinin E, Poggi S & Stein H (1993) PG-M1: a new monoclonal antibody directed against a fixative resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol, 142, 1359-1372.
25. Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X, Li Z & Ockleford CD (2000) Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation. Placenta, 21, 184-193.
26. Floridon C, Nielsen O, Holund B, Sweep F, Sunde L, Thomsen SG & Teisner B (2000) Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies. Placenta, 21, 754-762.
27. Frank HG, Malekzadeh F, Kertschanska S, Crescimanno C, Castellucci M, Lang I, Desoye G & Kaufmann P (1994) Immunohistochemistry of two different types of placental fibrinoid. Acta Anal (Basel), 150, 55-68.
28. Gilabert J, Estelles A, Grancha S, Espana F & Aznar J (1995) Fibrinolytic system and reproductive process with special reference to fibrinolytic failure in pre-eclampsia. Hum Reprod, 10(Suppl 2), 121-131.
29. Hattori N, Sisson TH, Xu Y, Desai TJ & Simon RH (1999) Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung. Am J Physiol, 277, L573-579.
30. Hoylaerts M, Rijken DC, Lijnen HR & Collen D (1982) Kinetics of the activation of plasminogen by human tissue plasminogen activator. J Biol Chem, 257, 2912-2919.
31. Huppertz B, Kertschanska S, Frank HG, Gans G, Funayama H & Kaufmann P (1996) Extracellular matrix components of the placental extravillous trophoblast: immunocytochemistry and ultrastructural distribution. Histochem Cell Biol, 106, 291-301.
32. Johnsen M, Lund LR, Rømer J, Almholt K & Danø K (1998) Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol, 10, 667-671.
33. Kaufmann P, Huppertz B & Frank HG (1996) The fibrinoids of the human placenta: origin, composition and functional relevance. Anat Anz, 178, 485-501.
34. Lang I, Hartmann M, Blaschitz A, Dohr G, Skofitsch G & Desoye G (1993) Immunohistochemical evidence for the heterogeneity of maternal and fetal vascular endothelial cells in human full-term placenta. Cell Tissue Res, 274, 211-218.
35. Lijnen HR (2001) Elements of the fibrinolytic system. Ann N Y Acad Sci, 936, 226-236.
36. Lund LR, Bjørn SF, Sternlicht MD, Nielsen BS, Solberg H, Usher PA, Østerby R, Christensen IJ, Stephens R, Bugge TH, Danø K & Werb Z (2000) Lactational competence and involution of the mouse mammary gland require plasminogen. Development, 127, 4481-4492.
37. Lund LR, Rømer J, Thomasset N, Solberg H, Pyke C, Bissel M, Danø K & Werb Z (1996) Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development, 122, 181-193.
38. Lyons RM, Keski Oja J & Moses HL (1988) Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol, 106, 1659-1665.
39. Mandriota SJ, Seghezzi G, Vassalli JD, Ferrara N, Wasi S, Mazzieri R, Mignatti P & Pepper MS (1995) Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem, 270, 9709-9716.
40. Mayhew TM & Barker BL (2001) Villous trophoblast: morphometric perspectives on growth, differentiation, turnover and deposition of fibrin-type fibrinoid during gestation. Placenta, 22, 628-638.
41. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S & Mignatti P (1997) Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J, 16, 2319-2332.
42. Min HY, Semnani R, Mizukami IF, Watt K, Todd RF3 & Liu DY (1992) cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J Immunol, 148, 3636-3642.
43. Mingers AM, Philapitsch A, Zeitler P, Schuster V, Schwarz HP & Kreth HW (1999) Human homozygous type I plasminogen deficiency and ligneous conjunctivitis. APMIS, 107, 62-72.
44. Murphy G & Docherty AJP (1992) The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol, 7, 120-125.
45. Nanaev AK, Kosanke G, Kemp B, Frank HG, Huppertz B & Kaufmann P (2000) The human placenta is encircled by a ring of smooth muscle cells. Placenta, 21, 122-125.
46. Nelson DM, Crouch EC, Curran EM & Farmer DR (1990) Trophoblast interaction with fibrin matrix. Epithelialization of perivillous fibrin deposits as a mechanism for villous repair in the human placenta. Am J Pathol, 136, 855-865.
47. Nielsen BS, Sehested M, Rank F, Duun S, Timshel S, Rygaard J, Johnsen M & Danø K (2001) Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer. Lab Invest, 81, 1485-1501.
48. Nielsen LS, Kellerman GM, Behrendt N, Picone R, Dano K & Blasi F (1988) A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification. J Biol Chem, 263, 2358-2363.
49. Odekon LE, Blasi F & Rifkin DB (1994) Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta. J Cell Physiol, 158, 398-407.
50. Parker RI & Gralnick HR (1986) Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factor. Blood, 68, 732-736.
51. Pepper MS, Sappino AP, Stocklin R, Montesano R, Orci L & Vassalli JD (1993) Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol, 122, 673-684.
52. Pierleoni C, Samuelsen GB, Græm N, Rønne E, Nielsen BS, Kaufmann P & Castellucci M (1998) Immunohistochemical identification of the receptor for urokinase plasminogen activator associated with fibrin deposition in normal and ectopic human placenta. Placenta, 19, 501-508.
53. Plesner T, Ploug M, Ellis V, Ronne E, Hoyer-Hansen G, Wittrup M, Pedersen TL, Tscherning T, Dano K & Hansen NE (1994) The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood, 83, 808-815.
54. Pyke C, Kristensen P, Ralfkiær E, Grøndahl-Hansen J, Eriksen J, Blasi F & Danø K (1991) Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol, 138, 1059-1067.
55. Pyke C, Ralfkiær E, Rønne E, Høyer-Hansen G, Kirkeby L & Danø K (1994) Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathol, 24, 131-138.
56. Rømer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL & Danø K (1996) Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med, 2, 287-292.
57. Selvarajan S, Lund LR, Takeuchi T, Craik CS & Werb Z (2001) A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol, 3, 267-275.
58. Sheikh H, Yarwood H, Ashworth A & Isacke CM (2000) Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor. J Cell Sci, 113, 1021-1032.
59. Simon DI, Rao NK, Xu H, Wei Y, Majdic O, Ronne E, Kobzik L & Chapman HA (1996) Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood, 88, 3185-3194.
60. Singh I, Burnand KG, Collins M, Luttun A, Collen D, Boelhouwer B & Smith A (2003) Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells. Circulation, 107(6), 869-875.
61. Sitrin RG, Pan PM, Srikanth S & Todd RF (1998) Fibrinogen activates NF-kappa B transcription factors in mononuclear phagocytes. J Immunol, 161, 1462-1470.
62. Sitrin RG, Todd RF, Albrecht E & Gyetko MR (1996) The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest, 97, 1942-1951.
63. Solberg H, Ploug M, Høyer-Hansen G, Nielsen BS & Lund LR (2001) The murine receptor for urokinase type plasminogen activator is primarily expressed in tissues actively undergoing remodeling. J Histochem Cytochem, 49, 237-246.
64. Takahashi R, Sekine N & Nakatake T (1999) Influence of monoclonal antiplatelet glycoprotein antibodies on in vitro human megakaryocyte colony formation and proplatelet formation. Blood, 93, 1951-1958.
65. Vassalli J, Baccino D & Belin D (1985) A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol, 100, 86-92.
66. Wanner A (1966) Wird bei der Geburtsplacenta des Menschen die Basalplatte von trophoblastzellen oder Zellen muetterlicher Herkunft ueberzogen? Acta Anat (Basel), 63, 545-558.